Clementien Vermont

Clementien Vermont is a researcher in the Department of Pediatrics at Erasmus MC, Faculty of Medicine. Her work focuses on pediatric infectious diseases, diagnostics, and host response to infection, with a strong emphasis on clinical and observational studies across European collaborative networks such as PERFORM, DIAMONDS, and EUCLIDS.

Her research interests lie at the intersection of pediatric emergency medicine and molecular diagnostics. She investigates host transcriptomic responses to differentiate bacterial from viral pneumonia, evaluates biomarkers like procalcitonin for infection severity, and contributes to improving diagnostic accuracy in febrile children. Her work supports precision medicine approaches in pediatric care.

The recent publications highlight a strong trend toward genomic and transcriptomic tools in pediatric infectious disease diagnostics. There is a clear focus on developing host-response biomarkers, improving triage in emergency departments, and applying systems biology to guide antibiotic use. These efforts are largely embedded in large-scale, multicenter European consortia.

While no formal scientific awards are listed in the provided text, her contributions to high-impact journals such as Nature Communications and iScience reflect recognition within the academic community. Her collaborative network spans multiple countries and institutions, indicating active engagement in international research.

She has contributed to the supervision of early-career researchers, with two supervised works listed. Though specific grants are not mentioned, her involvement in major consortia (e.g., PERFORM, DIAMONDS) suggests participation in large externally funded projects. Her role appears to be research-intensive, with a strong clinical translation focus.

Her research is conducted within collaborative teams embedded in the Erasmus MC Pediatrics department, particularly those focused on infectious diseases and emergency diagnostics. These teams work closely with European networks, contributing to large observational and translational studies aimed at improving pediatric patient outcomes.